More than a million HIV-infected persons in the South-East Asia Region (SEAR) remain without access to effective treatment. High cost of drugs and limited capacity of the respective health systems of the member-countries are primarily responsible for this situation which is only compounded by delays in diagnosing the disease and the stigma attached to it.